EGFR Mutations Detection Kit

A real-time PCR diagnostic kit for EGFR mutation detection. Used in solid tumour oncology for identifying epidermal growth factor receptor mutations in patient samples.

In vitro diagnostic kit for detecting EGFR gene mutations in patient samples. Enables molecular profiling of epidermal growth factor receptor status to guide targeted cancer therapy selection and treatment planning in oncology.

Molecular assay kit detecting EGFR gene mutations including EGFR-19del variant in tissue DNA and plasma cell-free DNA. Supports non-small cell lung cancer patient stratification and treatment selection.

Molecular assay for detecting EGFR gene mutations including 19-deletion variant in tissue and plasma circulating free DNA. Supports treatment selection and monitoring in non-small cell lung cancer patients.

A reagent kit designed for the combined detection of human EGFR and ALK gene mutations. The kit is used for molecular testing to identify specific genetic mutations in patient samples.

This kit is used to in vitro qualitatively detect common mutations in exons 18-21 of the EGFR gene in samples from human non-small cell lung cancer patients.

Diagnostic kit for analyzing cancer-related genetic mutations and biomarkers. Provides genomic information to support targeted therapy selection and treatment planning.

Molecular diagnostic kit for detecting genetic mutations and biomarkers associated with cancer. Supports precision oncology testing for treatment selection and monitoring.

An in vitro diagnostic reagent kit for qualitative detection of EGFR and ALK gene mutations in non-small cell lung cancer (NSCLC). The kit has received Class III medical device registration certification from the National Medical Products Administration and is used for clinical diagnosis in hospitals nationwide.

A real-time PCR diagnostic kit for KRAS mutation detection. Applied in solid tumour diagnostics for identifying KRAS gene mutations associated with various cancer types.

Molecular diagnostic kit for identification of specific genetic mutations associated with disease or resistance. Enables targeted diagnostic and therapeutic decision-making.

Kit for fast detection of actionable somatic FGFR3 mutations in solid tumors. Enables rapid identification of FGFR3 alterations for treatment decision-making.